Targene Biotech Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 8

Targene Biotech General Information

Description

Developer of molecular biology technology designed for diagnosis of cancer. The company mainly provides cancer screening kits and early diagnostic kits led by liquid biopsy technology and molecular diagnostic technologies such as gene methylation, enabling medical institution to improve work efficiency.

Contact Information

Website
www.targeneec.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 706, 905, No. 2, Tengfei 1st Street
  • Sino-Singapore Guangzhou Knowledge City, Huangpu District
  • Guangzhou, Guangdong
  • China
+86 020
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
TMT, Life Sciences, Oncology
Corporate Office
  • Room 706, 905, No. 2, Tengfei 1st Street
  • Sino-Singapore Guangzhou Knowledge City, Huangpu District
  • Guangzhou, Guangdong
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Targene Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A1) 10-Jun-2022 Completed Generating Revenue
1. Later Stage VC (Series A) 27-Mar-2020 Completed Generating Revenue
To view Targene Biotech’s complete valuation and funding history, request access »

Targene Biotech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guangzhou Ambition (LBP) Pharmaceutical Technology Corporation Minority
Guangzhou Fund Government Minority
Guangzhou Science and Technology Financial Innovation Investment Holding Venture Capital Minority
BGI Co-Win Corporate Venture Capital Minority
Funway Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Targene Biotech FAQs

  • When was Targene Biotech founded?

    Targene Biotech was founded in 2009.

  • Where is Targene Biotech headquartered?

    Targene Biotech is headquartered in Guangzhou, China.

  • What industry is Targene Biotech in?

    Targene Biotech’s primary industry is Diagnostic Equipment.

  • Is Targene Biotech a private or public company?

    Targene Biotech is a Private company.

  • What is Targene Biotech’s current revenue?

    The current revenue for Targene Biotech is .

  • How much funding has Targene Biotech raised over time?

    Targene Biotech has raised $14.3M.

  • Who are Targene Biotech’s investors?

    Guangzhou Ambition (LBP) Pharmaceutical Technology, Guangzhou Fund, Guangzhou Science and Technology Financial Innovation Investment Holding, BGI Co-Win, and Funway Capital are 5 of 8 investors who have invested in Targene Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process